Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 receptor agonists vs fixed-ratio combination of GLP-1RA + insulin after intensive insulin therapy in newly diagnosed type 2 diabetes
ChiCTR2600128323Phase 4Completed
- Sponsor
- Pudong New District People's Hospital
- Start
- Jul 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Pudong New District People's Hospital. Primary endpoints: Clinical remission of type 2 diabetes mellitus and Changes in pancreatic beta-cell function at week 48. Started Jul 2026; status: completed.
02
Drugs
human insulinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2600128323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128323.